Koninklijke Philips N.V. (NYSE:PHG) Q3 2025 Earnings Call Transcript November 4, 2025 Koninklijke Philips N.V. reports earnings inline with expectations. Reported EPS is $0.37 EPS, expectations were ...

Welcome to the Royal Philips' Third Quarter 2025 Results Conference Call on Tuesday, November 4, 2025. During the call hosted by Mr. Roy Jakobs, CEO; and Ms. Charlotte Hanneman, CFO, all participants ...

WASHINGTON – Philips Respironics has removed certain DreamStation devices due to programming errors that can result in failed therapy modes, according to the U.S. Food and Drug Administration. Philips ...

Philips sent updated instructions related to a problem with bilevel positive airway pressure, or BiPAP, machines that can cause interruption or loss of therapy. Philips recalled three models of BiPAP ...

Welcome to the Philips' Second Quarter and Semiannual 2025 Results Conference Call on Tuesday, July 29, 2025. During the call hosted by Mr. Roy Jakobs, CEO; and Ms. Charlotte Hanneman, CFO, all ...

The use of in-line nebulizers placed in certain locations may lead to aerosol deposits forming over time on the ventilator flow sensor. Should this occur, there is a possibility of inaccurate flow ...

The FDA is getting the word out on a mandatory software update from Philips for its Trilogy line of portable life support ventilators, used in both hospitals and the home. Philips’ Respironics ...

Philips recalled several models of its Trilogy ventilators because of multiple problems that can result in patients not receiving enough ventilation or oxygen. The company is asking users to install a ...